Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.
2.

Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.

Charney DA, Heath LM, Zikos E, Palacios-Boix J, Gill KJ.

Alcohol Clin Exp Res. 2015 Sep;39(9):1756-65. doi: 10.1111/acer.12802. Epub 2015 Jul 24.

PMID:
26208048
3.

The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.

Reid SC, Teesson M, Sannibale C, Matsuda M, Haber PS.

J Stud Alcohol. 2005 Nov;66(6):833-41.

PMID:
16459945
4.

Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial.

Moeller FG, Schmitz JM, Steinberg JL, Green CM, Reist C, Lai LY, Swann AC, Grabowski J.

Am J Drug Alcohol Abuse. 2007;33(3):367-78.

PMID:
17613964
5.

A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.

Adamson SJ, Sellman JD, Foulds JA, Frampton CM, Deering D, Dunn A, Berks J, Nixon L, Cape G.

J Clin Psychopharmacol. 2015 Apr;35(2):143-9. doi: 10.1097/JCP.0000000000000287.

PMID:
25679122
6.

Combining psychosocial treatment with pharmacotherapy for alcohol dependence.

Weiss RD, Kueppenbender KD.

J Clin Psychopharmacol. 2006 Dec;26 Suppl 1:S37-42. Review.

PMID:
17114954
7.

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

Mason BJ, Goodman AM, Chabac S, Lehert P.

J Psychiatr Res. 2006 Aug;40(5):383-93. Epub 2006 Mar 20.

PMID:
16546214
8.

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.

Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B.

Alcohol Alcohol. 2000 Nov-Dec;35(6):587-93.

PMID:
11093966
9.

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.

Naranjo CA, Bremner KE, Lanctôt KL.

Addiction. 1995 Jan;90(1):87-99.

PMID:
7888983
10.

Psychotherapeutic considerations in pharmacological trials.

O'Malley SS, Carroll KM.

Alcohol Clin Exp Res. 1996 Oct;20(7 Suppl):17A-22A. Review.

PMID:
8904990
11.

Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?

De Wildt WA, Schippers GM, Van Den Brink W, Potgieter AS, Deckers F, Bets D.

Alcohol Alcohol. 2002 Jul-Aug;37(4):375-82.

PMID:
12107041
12.
13.
14.

A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence.

Pakpour AH, Gholami M, Esmaeili R, Naghibi SA, Updegraff JA, Molloy GJ, Dombrowski SU.

Epilepsy Behav. 2015 Nov;52(Pt A):133-42. doi: 10.1016/j.yebeh.2015.08.036. Epub 2015 Sep 28.

PMID:
26414343
15.

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E.

Alcohol Alcohol. 2003 Mar-Apr;38(2):135-41.

PMID:
12634260
16.

Pharmacological treatment of alcohol dependence: a review of the evidence.

Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT.

JAMA. 1999 Apr 14;281(14):1318-25.

PMID:
10208148
17.

Using fuzzy logic to predict response to citalopram in alcohol dependence.

Naranjo CA, Bremner KE, Bazoon M, Turksen IB.

Clin Pharmacol Ther. 1997 Aug;62(2):209-24.

PMID:
9284858
18.

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.

Pettinati HM, Silverman BL, Battisti JJ, Forman R, Schweizer E, Gastfriend DR.

Alcohol Clin Exp Res. 2011 Oct;35(10):1804-11. doi: 10.1111/j.1530-0277.2011.01524.x. Epub 2011 May 16.

PMID:
21575016
19.
20.

The treatment of alcohol dependence.

Assanangkornchai S, Srisurapanont M.

Curr Opin Psychiatry. 2007 May;20(3):222-7. Review.

PMID:
17415073

Supplemental Content

Support Center